This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.
Insights Insights
| 1 minute read

Taylor English Welcomes Dr. Zhaoyang (Paul) Li To Intellectual Property Group

Taylor English Duma LLP is pleased to announce the addition of Dr. Zhaoyang (Paul) Li as a partner in the firm’s Intellectual Property practice group. With a Ph.D. in chemistry and fluency in Mandarin, Dr. Li helps his clients navigate the complex nature of Chinese trade secrets and intellectual property rights.

Dr. Li’s practice includes patent prosecution, patent infringement assessment, patent right licensing agreements, patentability and intellectual property counseling and due diligence. He handles patent litigation for a wide array of technology companies in the biotechnology, biopharmaceuticals, stem cell technologies, telecommunications and electronics industries. He also counsels clients on small molecule pharmaceutical patent matters, including new chemical entity and formulation patents, and related Paragraph IV certification issues in association with new drug application or abbreviated new drug application matters. Additionally, Dr. Li has experience facilitating legal teams to tackle oil and gas, engineering, procurement and construction projects for Chinese state-owned enterprises and large companies in China’s private sector.

Dr. Li works closely with entrepreneurs and inventors on intellectual property protection and commercialization issues. Dr. Li has experience working with startup companies on global intellectual property strategic planning and helps clients build and grow a strong patent portfolio protecting clients’ core technologies. 

Dr. Li is a regular speaker on topics related to intellectual property. During the 2005 Hong Kong Jockey Club Traditional Chinese Medicine (TMC) Institute Symposium, Dr. Li presented on intellectual property protection related to prior art challenges faced by the TMC. He proposed a TMC intellectual property protection protocol, known as “finger printing,” which is now widely used.

Representative of his work, Dr. Li was listed in the 2014 and 2015 Legal 500 in the Intellectual Property and Patent Licensing and Transactional categories. He is a member of the American Bar Association and the American Intellectual Property Law Association (AIPLA).

Dr. Li earned his undergraduate degree from Nankai University in Tianjin, China; his Ph.D. in chemistry from the University of South Carolina; and his law degree from Vanderbilt Law School.


li_paul, news, careers